Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The efficacy of raloxifene versus placebo was compared over a six-month period, as an
adjuvant treatment of the negative symptoms of schizophrenia in a group of 80 post-menopausal
women. The aim of the study is to analyze whether raloxifene has an effect on the positive
and negative symptoms of schizophrenia, and on psychopathological symptoms in general, and on
social and neuropsychological functioning, and to study the influence of genetic
polymorphisms in treatment response.
Phase:
Phase 3
Details
Lead Sponsor:
Fundació Sant Joan de Déu
Collaborators:
Hospital Sant Joan de Deu Parc Sanitari Sant Joan de Déu Stanley Medical Research Institute